Paul, Reid
December 2011
Pharmaceutical Representative;Dec2011, Vol. 41 Issue 12, p18
An interview with Matt Gurin, the U.S. Reward Practice Leader for Life Sciences, is presented. When asked about the impact of technologies such as the iPad on pharmaceutical sales, he stresses that such technologies have driven pharmaceutical companies to focus on new product development and branding strategies to increase sales. Gurin discusses the changes in the practice environment for physicians as a result of emerging technology. He also comments on U.S. healthcare reform.


Related Articles

  • The Pharm a 2.0 transformation.  // Pharmaceutical Technology Europe;Jan2010, Vol. 22 Issue 1, p10 

    The article discusses the report released by Ovum for the pharmaceutical industry in Great Britain. According to the report, the industry is in a transformation because of increased regulations, internet advertising, and personalized medicine. According to the report, major changes will be...

  • In the Pipeline - Health Care Reform and the Drug Industry: How Goes It?  // Contract Pharma;Mar2011, Vol. 13 Issue 2, p29 

    The article focuses on the impact of the health care reform bill on the pharmaceutical industry in the U.S. It notes that the bill expands the worst sectors of the industry while degrading the best. It adds that on the accounts of its effect on the industry, the Medicaid will be expanded by 16...

  • Innovating in a limited-resource world. Posey, L. Michael // Pharmacy Today;Feb2011, Vol. 17 Issue 2, p4 

    In this article the author discusses aspects of innovation in the pharmaceutical industry in the U.S. He notes that pharmacists will need to work with other providers in forming accountable care organizations (ACOs) and medical homes as health care reform proceeds. He states that medication...

  • Adherence's New Players: Fresh Support from the Sidelines. Herman, Clark // Pharmaceutical Executive;Jun2013, Vol. 33 Issue 6, p26 

    The article discusses the factors influencing medication adherence in the U.S. The impact of innovative technologies and the healthcare reform on patient compliance to medications is highlighted. The role of the pharmaceutical industry in facilitating the promotion of medication adherence is...

  • WEEK IN WASHINGTON.  // BioWorld Insight;3/1/2010, Vol. 18 Issue 9, p7 

    The article offers news briefs related to pharmaceutical industry including the health reform proposal guidance for clinical trials and human embryonic stem cells.

  • As I See lt. Kamp, John // Medical Marketing & Media;Sep2010, Vol. 45 Issue 9, p32 

    In this article, the author reflects on the impact of the health care reform bill on the pharmaceutical industry in the U.S.

  • "Pharma Value". Nash, David B. // American Health & Drug Benefits;Sep/Oct2013, Vol. 6 Issue 8, p448 

    The author offers insights on the report "Top Health Industry Issues of 2013--Picking Up the Pace on Health Reform," published by PricewaterhouseCoopers Health Research Institute. He discusses the significant interest of healthcare consumers in value and the drug value-related pressure that...

  • When the Payer is the Player.  // Pharmaceutical Executive;Oct2010, Vol. 30 Issue 10, p32 

    An interview with the Arcas Group president Jan Heybroek and PriceSpective partner Ted Sweeny concerning the U.S. healthcare system is presented. Heybroek and Sweeney reveal the hopes and fears of pharmaceutical companies regarding the expanding power of private payers such as insurance...

  • Digital Alternatives Define New Sales Force. Cooney, Bill // Pharmaceutical Executive;Oct2010, Vol. 30 Issue 10, p18 

    The article focuses on digital alternatives for speaker programs which define pharmaceutical sales force of pharmaceutical companies in the U.S. It notes the significant role of speaker programs in medical marketing, stressing the shift of speaker programs from dining venues to digital media to...


Read the Article


Sign out of this library

Other Topics